Jennifer Allport-Anderson hunts for cardiac cures.
Novartis researchers have discovered a compound that is showing promise against three parasites that...
Compound offers a potential tool for fighting drug-resistant malaria parasites.
Jay Bradner, President of the Novartis Institutes for BioMedical Research (NIBR) and Vas Narasimhan, Head of Global...
Novartis focuses its business on three divisions with innovation power and global scale: pharmaceuticals, eye care and generics.
This site is intended for a global audience.